%0 Journal Article %K Adjuvant %K Immunologic %K leprosy %K Safety %K Vaccine %B Vaccine %D 2019 %G eng %R 10.1016/j.vaccine.2019.12.050 %T A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA-SE) in healthy adults. %1 https://www.ncbi.nlm.nih.gov/pubmed/31899025 %8 12/2019